Role of TSG101 Gene in Cervical and Endometrial Cancers
Author Information
Author(s): Chang J-G, Su T-H, Wei H-J, Wang J-C, Chen Y-J, Chang C-P, Jeng C-J
Primary Institution: Mackay Memorial Hospital, Taipei, Taiwan
Hypothesis
What is the role of the TSG101 gene in the carcinogenesis of cervical and uterine carcinoma?
Conclusion
The TSG101 gene may not function as a traditional tumor-suppressor gene, as abnormal transcripts were found in both cancerous and non-cancerous tissues.
Supporting Evidence
- Abnormal transcripts of the TSG101 gene were common in both cancerous and non-cancerous tissues.
- There was no genomic deletion or rearrangement despite the presence of abnormal transcripts.
- Normal peripheral mononuclear cells also had abnormal transcripts.
Takeaway
Researchers looked at a gene called TSG101 in women with cervical and uterine cancer and found that it was often abnormal, even in healthy tissue.
Methodology
The study analyzed genomic DNA and TSG101 mRNA from cancerous and non-cancerous tissues using Southern blot analysis, PCR amplification, and sequencing.
Limitations
The study did not establish a definite relationship between abnormal transcripts and HPV infection.
Participant Demographics
19 cases of cervical carcinoma, 5 cases of endometrial carcinoma, and 16 healthy controls.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website